Journal of clinical medicine · 2026
Thromboembolic and Mortality Risk in Patients with Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft-The TRIP-AF Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pedretti Roberto F E, Addeo Lucio, Campana Pasquale, Angeli Fabio, Bussotti Maurizio, Caporotondi Angelo, Cattadori Gaia, Cremona Valentina, Crotti Lia, De Salvo Maria, Facchini Mario, Frisinghelli Anna, Grati Paola, Grieco Niccolò B, La Rovere Maria Teresa, Papa Antimo, Passantino Andrea, Passera Martina, Picozzi Anna, Tarro Genta Franco, Racca Vittorio, Rizza Vincenzo, Rossi Maria Cristina, Sarzi Braga Simona, Scalvini Simonetta, Vaninetti Raffaella, Venturini Elio, Zanelli Emanuela, Galati Alfonso, Mallardo Mario, Dalla Vecchia Laura
Аннотация
Background/Objectives: Postoperative atrial fibrillation (POAF) is a common complication of coronary artery bypass grafting (CABG) and may recur during cardiac rehabilitation (CR); its long-term prognostic value remains unclear. We evaluated the impact of POAF on a composite endpoint of all-cause mortality and non-fatal stroke after isolated CABG and assessed POAF duration and timing, AF recurrence, and other predictors of adverse outcomes. Methods: This multicentre retrospective study enrolled 1139 patients who underwent CR after isolated CABG between 2011 and 2015 across 17 Italian centres. Clinical and outcome data were obtained from medical records and structured interviews; median follow-up was 5.78 years. Results: POAF occurred in 34.3% of patients and was associated with a higher incidence of the primary composite endpoint of all-cause mortality and non-fatal stroke in univariate analysis (15.4% vs. 10.0%, p = 0.008), particularly when lasting ≥48 h or occurring during both surgery and rehabilitation. However, in multivariate analysis POAF was not an independent predictor; instead, CHA2DS2-VASc score ≥3, reduced left ventricular ejection fraction, elevated urea, history of heart failure, and AF recurrence during follow-up predicted adverse outcomes. Conclusions: POAF reflects early vulnerability but does not independently predict long-term mortality or stroke. Conversely, AF recurrence and CHA2DS2-VASc score retain strong prognostic value, underscoring the need for long-term rhythm monitoring and individualised risk assessment post-CABG.